Do Therapy Dogs Improve Behavior and Reduce Anxiety in Pediatric Dental Patients?
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Sep 21, 2023
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 3-7
- • Children who are patients at the Medical University of South Carolina Department of Pediatric Dentistry
- • Children classified as category 1 or 2 according to the American Society of Anesthesiologists Physical Status Classification
- • Children whose parents/guardians are willing to consent to the child participating in the study
- • Availability of parent to be present during treatment
- • Children who require further care that includes the injection of a local anesthetic and whose procedure will take less than one hour
- Exclusion Criteria:
- • Patients whose cases are considered emergencies
- • Patients who are classified as category 3 or higher according to the American Society of Anesthesiologists Physical Status Classification (6)
- • If patient's medical status has worsened since initial evaluation
- • Known allergy to dogs or other animals
- • Past history of dental trauma
- • Past history of animal bites or traumatic experience with a dog
- • Emotional or developmental delays
- • If, on the day of the treatment, patient presents with fever or other illness
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Trial Officials
Julie L Marshall, PhD
Principal Investigator
James B. Edwards College of Dental Medicine, Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported